INTRODUCTION:

Sickle cell disease (SCD) is a genetic blood disorder, an inherited condition marked by the production of irregular hemoglobin molecules that transform red blood cells into a crescent or sickle shape. This disorder impacts millions globally, especially individuals of African, Mediterranean, Middle Eastern, and South Asian heritage. SCD greatly influences the health and quality of life of those diagnosed. The primary underlying cause of SCD is a genetic mutation in the gene responsible for hemoglobin production, the protein that transports oxygen in red blood cells. This mutation results in abnormal hemoglobin known as hemoglobin S, which causes red blood cells to become rigid and sticky, leading to their distortion and diminished capacity to navigate through small blood vessels, which cause a range of health issues. The primary symptom is repeated episodes of intense pain, referred to as vaso-occlusive crises. Individuals with SCD may suffer from chronic pain, fatigue, anemia, and a heightened risk of infections. The clinical features of SCD are varied and can range in intensity among different individuals. These manifestations can greatly affect the everyday lives of individuals with SCD, impacting their physical and psychological well-being. Treatments for SCD focus on alleviating symptoms, preventing complications, and enhancing patients’ quality of life. Effective pain management is essential and typically includes the use of analgesics such as opioids, nonsteroidal anti-inflammatory drugs, and adjuvant therapies. Maintaining proper hydration, both orally and through intravenous means, is crucial to ensure adequate blood flow and prevent the sickling of red blood cells.

In certain cases, regular blood transfusions may be necessary to enhance oxygen delivery to tissues and lower the risk of complications like stroke. Hydroxyurea, a medication that boosts the production of fetal hemoglobin (HbF), has been shown to effectively reduce the frequency and severity of pain crises in SCD. HbF helps prevent the sickling of red blood cells, improving their longevity and overall clinical results. Additionally, bone marrow or stem cell transplants may provide a potential cure for some individuals with severe SCD, although the availability of donors and associated risks constrain this option.

M, Kilonzi., D. L. Mwakawanga., et. al. (2022). The study "The Effects of Sickle Cell Disease on Quality of Life: A Focus on Parents in Tanzania" evaluates the impact of SCD on children and their parents. It identifies three main themes: psycho-social effects (family conflicts, limited education access, and stress), financial effects (employment limitations and reduced income), and physical effects (disability and crisis burden). Recommended interventions aim to improve the quality of life for those affected by SCD and their caregivers.

Camila, R., Thiago, R., et. al. (2021). The research “Prejudice Impairing Quality of Life in Sickle Cell Disease Patients in a Developing Country: Face of suffering” highlights how patients with sickle cell disease (SCD) face stigmatization and prejudice, which exacerbates their suffering. SCD leads to complications like chronic anemia, pain, and organ damage, significantly reducing health-related quality of life over time. This condition hampers the ability to engage in work, school, and family activities. The findings emphasize the need for improved care for SCD within the Public Health System and align with the National Policy for Integral Care for individuals with SCD.

Adegboyega, L. O. (2021). In the study "Psycho-social problems of adolescents with sickle-cell anemia in Ekiti State, Nigeria," it was found that adolescents with sickle-cell anemia face limited career choices, difficulties in finding suitable marriage partners, and exhibit emotional disturbances, misbehavior, and learning issues. Differences in psycho-social problems were noted based on age and educational level. It’s recommended that social workers be employed in healthcare settings to support these adolescents during clinic visits, while counselors should focus on helping them cope in school and society.

Bontha V. B., Parikipandla S., et. al. (2020). In the study “Improving the Capacity of Health System and Community for Sickle Cell Disease Screening and Management Among tribal Population in India: Protocol of an Intervention Study,” it was identified that Interventions for managing SCD are not effectively reaching tribal communities, and a comprehensive program is lacking in the healthcare system. The Indian Council of Medical Research is conducting a nationwide study to create an effective intervention model for SCD patients in these areas. This includes raising awareness, facilitating access to government healthcare, and training healthcare providers in SCD prevention and management.

P. Sundd. and E. M. Novelli. (2019). In “Pathophysiology of Sickle Cell Disease.” Sickle Cell Disease is discovered in 1910. According to the Systematic Analysis of the Global Burden of Disease study, 3.2 million people live with SCD, 43 million people have Sickle Cell Trait (Carriers), and 176,000 people die of SCD-related complications per year around the world.

Roshan B. Colah,. Malay b. Mukherjee, and et. al. (2015). “Sickle cell disease in tribal populations in India.” Most of the tribal populations where sickle cell disease is common rely on the primary health care facilities in rural and often remote areas. Medical genetic services aim to support individuals with genetic disadvantages in rural and remote areas by providing access to quality care, social support, and genetic counseling for informed reproductive choices. The Indian Council of Medical Research (ICMR) and the National Rural Health Mission (NRHM) have launched initiatives to bring genetic advancements to these communities.

April S and Raymona L . (2015). This study, “The Sociology of Sickle Cell Disease.” highlighted that living with Sickle Cell Disease is to live with a disease that many people don’t understand and many doctors don’t know how to properly treat. Sickle Cell Disease shows us how social constructions and social structure profoundly change the experience of living with a chronic disease. Those living with sickle cell disease experience a wide variety of racial healthcare disparities. When the debilitating pain of sickle cell forces a patient into the emergency room, they often find that the medical staff is unable to provide adequate care.

About The Ethnic Group:

India holds the highest concentration of tribal communities in the world. They are considered among the nation's earliest settlers and are regarded as the indigenous population. An Australian researcher, Edward Suess, proposed a theory in 1885 suggesting that “Antarctica, Australia, India, and South America were once united as a single continental landmass, referred to as Gondwana land, named after the Gondwana region of India.” It is indicated that “possibly during the early Mesozoic era, around 200 million years ago, Gondwana land likely fragmented into individual continents that drifted apart like massive terrestrial icebergs atop the Earth's pliable mantle.” The Span magazine has cited references from the American Science and Imperial Gazetteers of India, as well as (Mehta,1984).

As per the Census of India 2011, tribal individuals constitute 8.6 percent of the overall population, equating to approximately 67.8 million. The states of Madhya Pradesh, Maharashtra, Odisha, Gujarat, Rajasthan, Jharkhand, Chhattisgarh, Andhra Pradesh, West Bengal, and Karnataka collectively represent around 83 percent of the country’s scheduled tribe population, with most of these groups residing in rural areas. In total, there are 461 recognized scheduled tribes, each possessing distinct cultural practices, languages, and social structures, generally maintaining their way of life.

A significant number of Indian tribal groups trace their ancestry back to strong founder events, which underscores the need to identify recessive genetic disorders within these populations and to map the associated genes. Thousands of years ago, the entire subcontinent experienced a significant period of intermarriage, which thoroughly reshuffled the genetic landscape of the population, leaving evident markers in the genomes of today's most isolated tribes (David Reich, Kumarasamy Thangaraj and et. al., 2009).

India has one of the highest frequencies of the hemoglobin S allele globally. It ranks third in the number of infants born with HbSS and Total of 17 states with higher prevalence of SCD viz., Gujarat, Maharashtra, Rajasthan, Madhya Pradesh, Jharkhand, Chhattisgarh, West Bengal, Odisha, Tamil Nadu, Telangana, Andhra Pradesh, Karnataka, Assam, Uttar Pradesh, Kerala, Bihar and Uttarakhand (Ministry of Health and Family Welfare and Ministry of Tribal Affairs). This disease can be found in various ethnic and geographical groups. Numerous population groups have been examined, and studies indicate that the sickle cell gene is widespread among three socio-economically disadvantaged ethnic categories: scheduled tribes, scheduled castes, and other backward classes in India. The Gonds and Bhils are the largest tribal populations found in central India. This includes the Bhils, Madias, Pawaras, Pardhans, and Otkars. Furthermore, it is estimated that the districts of Gadchiroli, Chandrapur, Nagpur, Bhandara, Yavatmal, and Nandurbar may have over 5,000 instances of sickle cell anemia. The occurrence of the beta-sickle globin mutation (βS) is notably prevalent among Indigenous tribal populations (Adivasis), who constitute over 8% of the total population, and historically marginalized groups known as scheduled castes, making up more than 10% of the population (208 million out of more than 1.4 billion people). In these groups, approximately 1 in 86 births is affected by sickle cell disease. The prevalence of sickle cell disease has been thoroughly documented in the Atlas on Haemoglobinopathies, published by the Indian Council of Medical Research and the National Institute of Immunohaematology in February 2022 (Jain, Dipty., Gupta, Mihir,. and et. al., 2024).

BACKGROUND:

Research shows that the mutation causing sickle cell disease originated in Africa thousands of years ago as a defense against malaria. This mutation can be linked to at least four separate occurrences: three in Africa and one in either Saudi Arabia or central India, occurring between 3,000 and 6,000 generations ago, approximately 70,000 to 150,000 years ago. (The Sickle Cell Association of New Jersey, Inc.).

Sickle Cell Disease is a relatively common condition, affecting approximately one in ten Black Americans who carry the trait, with one in 375 developing the disease. In the UK, it affects one in every 2,000 births, making it one of the most prevalent recessive disorders. The disease is particularly common among individuals of sub-Saharan African, Hispanic, Mediterranean, East Indian, and Middle Eastern descent. Historically, it has been associated with race since its early recognition. Physician Verne Mason noted its prevalence among African Americans in 1922, referring to it as unique to that race. Awareness of Sickle Cell also grew during the enslavement of Africans. Commonly known as the ‘Black disease,’ Sickle Cell was often confused with malaria due to similar symptoms, leading to misdiagnoses of related deaths before the 1950s. This confusion led some doctors to call it the ‘great masquerader’.

Dr. Robert Lebby Jr. documented an early case in 1846 in the Southern Journal of Medical Pharmacology, detailing an autopsy on an enslaved man executed for attempting to escape. The man had leg ulcers and experienced fevers. The autopsy revealed he had no spleen, likely due to Sickle Cell Disease, which causes spleen atrophy from interrupted blood supply.

Medical professionals first recognized this condition in the Archives of Internal Medicine in November 1910 when Chicago doctor James B. Herrick identified it in a twenty-year-old dental student, Walter Clement Noel. He theorized that these misshapen cells had difficulty moving through blood vessels, obstructing them and hindering oxygen delivery to tissues.

Nearly forty years later, chemist Linus Pauling and his colleagues discovered that sickle cell disease results from a defect in the hemoglobin molecule. In their 1949 publication, they noted that some individuals' red blood cells can change shape in response to oxygen levels, transforming from a biconcave disk to a crescent shape when oxygen decreases. The condition is inherited recessively, meaning a person needs to inherit the gene from both parents to show severe symptoms. The mutation involves the substitution of Hemoglobin A with Hemoglobin S, causing sickling when oxygen is released and forming hemoglobin polymers. Pauling termed this phenomenon ‘Sickling’.

Despite its prevalence, public awareness of the disease was notably low until the 1970s, even in Black communities. A 1969 article found only 20% of Black adults were aware of it. A study in Boston revealed that less than half of Black families knew about Sickle Cell Disease, and none recognized its hereditary nature.

As of 2006 in the UK, there were no national clinical guidelines for sickle cell disease. The first successful treatment through a bone marrow transplant occurred the same year, but many patients lack suitable donors. While stem cell transplantation can cure the disease, it is very costly. Hydroxyurea became the first effective medication to alleviate pain by boosting fetal hemoglobin production, a finding attributed to pediatrician Janet Watson. Today, most patients still depend on pain management, hydration, oxygen therapy, and antibiotics for treatment.

Additionally, screening for the condition is a highly politicized and racialized process, where 'carrier' status is central to discrimination. Moreover, there are multiple reasons for Black communities to feel distrustful of white physicians and geneticists who aimed to create screening programs focused solely on them, and the strategy behind this was to decrease the birth rate within Black communities. Even in the late 1980s, a so-called ‘respected scientist’ suggested tattooing an individual's sickle cell carrier status on the forehead of anyone possessing the trait to curb transmission. This status impacts marriage and parenting opportunities.

The higher prevalence of Sickle Cell Disease among African Americans compared to Africans was often attributed to 'racial mixing' in the U.S., as noted by Melbourne Tapper in "In the Blood: Sickle Cell Anemia and the Politics of Race" (1999). While he acknowledged some hereditary predisposition, he emphasized that poverty, ignorance, and social deprivation were the main factors affecting health in these communities.

The civil rights movements of the 1960s significantly impacted Black lives, especially regarding health issues like Sickle Cell Anemia. Activists viewed the disease as a symbol of discrimination and a rallying point for better living conditions. The Black Panther Party, established in 1966, criticized the government’s neglect of Sickle Cell Disease, highlighting its indifference toward Black lives. They launched public health initiatives to educate the community, provide genetic testing, and connect Sickle Cell politics to systemic racism.

Even President Richard Nixon acknowledged the political benefit of highlighting Sickle Cell Disease as a way to show his support for Black issues. On February 18, 1971, he referenced the disease in his health address to Congress. A year later, the National Sickle Cell Anemia Control Act was enacted, allocating funds for research on the disease.

While similar issues were present in Britain, factors like empire, decolonization, and migration played significant roles. Grace Redhead, in her insightful article titled “‘A British Problem Affecting British People’: Sickle Cell Anaemia, Medical Activism and Race in the National Health Service, 1975-1993,” highlights the irony that migrants from the former British empire helped create and shape the welfare state, yet were branded as ‘welfare parasites’ for utilizing it. By the late 1960s, almost one-third of nurse vacancies were filled by Commonwealth migrants, and by the mid-1970s, 18 to 32 percent of hospital workers were born outside of Britain. Despite their contributions, these workers faced accusations of introducing the ‘Black Blood disease’ to a ‘white England’ and spreading it in NHS wards.

India, the world's most populous country, has one of the highest frequencies of the sickle hemoglobin (HbS) allele. Traditionally, sickle cell disease (SCD) in India was seen as less severe, but recent advancements in screening and management reveal that its severity is comparable to global levels. First identified in the Nilgiri Hills of Tamil Nadu in 1952, the sickle cell gene is now widespread in the Deccan plateau and areas of northern Kerala and Tamil Nadu, with some communities showing up to 35% prevalence of the trait, as mapped by the Anthropological Survey of India.

Lehmann and Cutbush first identified sickle cell trait among the indigenous peoples of Southern India in 1952. Sickle cell trait and anemia have primarily been observed in individuals of African descent. This suggests that studying specific Southern Indian communities could either confirm or contest a racial link between Africa and India. Aboriginal tribes were chosen for this investigation, as they were expected to yield positive results. The classification of South Indian populations is debated, with distinctions between settled Dravidians and Pre-Dravidians facing linguistic and cultural objections. In the Nilgiri Hills, tribes like the Irulas and Kurumbas exist alongside more advanced agricultural societies like the Badagas. These findings support theories of ancient migration from India to Africa, while an African influx introducing sickle-cell traits would likely have increased the presence of certain gene combinations in Southern India.

Dunlop and Mazumder reported the presence of HbS among migrant tribal laborers in Bihar and Odisha's eastern states and within the tea plantations of Assam in the Northeast. The observations of the βS-globin (βS) trait provided the basis for a proposed population exchange between India and Africa, contributing to the milder phenotype. It has since been reported that SCD also impacts non-aboriginal groups. (Bourke, 2023)

Given that SCD was most prevalent among aboriginal (scheduled tribes) and marginalized groups, many likely went undiagnosed and/or did not survive due to lack of access to medical care, potentially leading to a limited understanding of the disease's characteristics. Recent studies have shown that SCD is not exclusive to these communities.

The Gond and Sickle Cell Disease in Chhattisgarh:

The Gonds tribe is one of India's largest tribal communities, mainly found in central and eastern regions. According to the 2011 census, the Gond population is 13,256,928, accounting for 13.45% of India's total tribal population of 10.43 crore. The highest concentrations are in Chhattisgarh (55.3%), followed by Madhya Pradesh (43.69%), Maharashtra (19.45%), Odisha (9.97%), and Bihar (1.57%). Uttar Pradesh also has a significant percentage of 50.16%.

The Government of India recognizes Scheduled Tribes under Article 342 of the Constitution, including the Gond and its sub-castes. Known as 'Adivasis' (meaning 'ancient inhabitants'), these tribes make up 8.6% of India's population, according to the 2011 census, making India home to the largest tribal population in the world. The Gond tribe is particularly significant and is found primarily in Madhya Pradesh, Chhattisgarh, Maharashtra, Telangana, Andhra Pradesh, Odisha, and Jharkhand.

The Gond is the major Dravidian tribe that once inhabited the greater part of the Central Province, which was called Gondwana. The Gonds and Khonds called themselves Koi or Koitur, which means ‘hill person’ or ‘dweller in the hills. The Gonds and Khonds were originally one tribe that got divided through migration. (Russell and Hiralal, 1916)

The Gond tribe is the largest tribe of Chhattisgarh state. It is spread in the northern, central, and southern regions of the state. According to the 2011 census, the total number of the Gond tribe in Chhattisgarh is 42,98,404. Their main residence areas are Bastar, Kanker, Kondagaon, Sukma, Bijapur, Narayanpur, Dhamtari, Bilaspur, Korba, Surguja, Korea, Kawardha, etc., districts. The Gond tribe is concentrated in almost all the districts of the state.

Several sub-castes of Gonds reside in Bastar, such as Maria, Madia, Muria, Abujhmaria, Dandami Madia, Dhurva, etc. The main language of the Gond tribe is 'Gondi', which is a dialect of the Dravidian language group but about half of the Gond tribe population also speaks Indo-Aryan dialects, including Hindi. Gonds traditionally practice agriculture and other major activities, including collecting forest produce, fishing, hunting, making metal goods in a cottage industry, and other primary sector activities. Gonds also have a special skill that is inherited from generation to generation and that is the secret of medicinal plants. Since many areas do not have proper health facilities, they still follow traditional medicine and use plants and herbs to treat various diseases. The Gond tribe is the most culturally rich tribal group in the country. The oldest cultural tradition has existed in this tribal community. Ghotul, the center of their main culture, has been world famous. Thus, the entire life of the Gond tribe is steeped in culture from birth to death. (Tribal Research and Training Institute, n.d.).

Tribal communities in India, in general, and of Chhattisgarh state in particular, are highly vulnerable to various genetic diseases, nutritional deficiencies, unrealistic practices, and lack of access to basic health facilities. Tribal people are engrossed with superstitions and have faith in traditional healers who practice magic-religious rites along with indigenous herbal treatment for common ailments. Traditional folk medicine and health, culture play a significant role in shaping tribal life. But in the case of SCD, there is no evidence found about curing the disease. There are lots of diseases that the Gond tribes cure, like Jaundice, Diabetes, Epilepsy, Anemia, etc. Even though many people in rural areas claim that they can cure SCD, there is no information about their success rate. Because of this type of false claim, many deprived people get diverted from medical treatment and lose their lives.

In the Gond tribe, “Dudh-lautawa” or ‘bringing back the milk’, consanguineous marriage, or marriage between first cousins and close relations, has been a common practice for centuries (Russell, R. V., Hiralal, Rai Bahadur, 1916), such marriages may be seen as advantageous for preserving family ties and inheritance, but they also come with potential genetic problems. This is because when cousins who are blood relatives have children together, there is a higher likelihood of inheriting the same recessive genes from their shared ancestors. These genes may carry harmful mutations, leading to various genetic disorders and conditions. (Zaman, 2010). This marriage practice within the Gond tribe is also the biggest reason for the sickle cell prevalence in this tribal community. They are unaware that this disorder is caused by marriage to close relatives. That is why this disease is very common in this community, especially those who are living in a remote area like South Chhattisgarh's Bastar region.

A 2013 report from the Jawahar Lal Nehru Memorial Medical College in Raipur, the capital of the state, indicates that 10 percent of Chhattisgarh's population is impacted by the disease, with the indigenous tribal community facing a greater burden. The State Health Resource Centre in Raipur reports that 20 percent of individuals from the Gond tribe are affected by the disease. Among Chhattisgarh’s 7.5 million indigenous tribal residents, at least 20 percent, especially within the Gond tribe, are afflicted by sickle cell disease, as stated by Dr. Patra.

District-wise Data of Sickle Cell Patients in Chhattisgarh (Sunil, 2023)

S. No.	District (Chhattisgarh)	No. of Patient
1.	Raigarh	21,04,552
2.	Raipur	2,92,823
3.	Mahasamund	15,88,104
4.	Dhamtari	73,845
5.	Mungeli	99,346
6.	Gariyabandh	86,617
7.	Durg	55,948
8.	Baloda Bazar	3,369
9.	Balod	56,110
10.	Kabirdham	45,811
11.	Kondagaon	26,012
12.	Korba	26,813
13.	Dantewada	34,414
14.	Jashpur	32,315
15.	Bastar	10,616
16.	Narayanpur	12,817
17.	Bilaspur	119

Causes of Sickle Cell Disease in Gond Tribes:

1. Limited Access to Healthcare and Education:

Lack of Awareness: In the Gond tribe, there is limited awareness about sickle cell disease and the sickle cell trait. People may not realize that they carry the gene or that marrying another carrier increases the risk of having a child with the disease. This lack of awareness is often due to limited access to health education and genetic counseling.

Delayed Diagnosis and Limited Healthcare Resources: Deprived communities often face challenges in accessing healthcare services, including early diagnosis and treatment for sickle cell disease. Many individuals with the disease may not be diagnosed until they face severe symptoms or complications, leading to delayed interventions.

2. Cultural and Social Factors:

Increased Intermarriage Among Carriers: In many deprived or rural communities, there may be limited marriage prospects outside one's immediate community due to social, cultural, and economic factors. This leads to more intermarriage between carriers of the sickle cell trait, increasing the likelihood of offspring inheriting two copies of the sickle cell gene, resulting in sickle cell disease.

Social Stigma: In some societies, genetic disorders such as sickle cell disease may carry a social stigma, preventing people from seeking the necessary support and medical care. This can result in poorer management of the disease, worsening health outcomes for affected individuals.

3. Economic Barriers:

Poverty and Limited Resources: Poverty can lead to a cycle where individuals and families lack access to essential healthcare services, including genetic counseling, prenatal care, and sickle cell screening programs. Without proper screening, people may unknowingly pass on the sickle cell trait to their children.

Inability to Afford Treatment: Deprived communities often struggle to afford the treatments necessary to manage sickle cell disease. Pain crises, blood transfusions, and medications such as hydroxyurea are often inaccessible to people from low-income backgrounds, leading to poorer health outcomes and an increased burden of the disease on affected individuals.

4. Challenges in Genetic Counseling and Prevention:

Lack of Preventive Programs: In many impoverished regions, there is often insufficient access to genetic counseling and sickle cell disease awareness programs. These programs are crucial in informing individuals about the risk of having children with sickle cell disease and the importance of early testing.

Limited Newborn Screening: In many low-income areas, newborn screening for genetic disorders like sickle cell disease may not be routinely offered, meaning that many children with sickle cell disease go undiagnosed until later in life, when complications become more severe.

Social Stigma and Prejudice Against Sickle Cell Disease in the SocietyL:

Social stigma and prejudice against sickle cell disease (SCD) are significant challenges that patients and their families often face. These negative perceptions can have a profound impact on the emotional well-being, social interactions, and overall quality of life of those affected by the disease.

1. Misunderstanding and Lack of Awareness:

Lack of Knowledge: Many people, including those in healthcare settings, may not fully understand sickle cell disease or the realities of living with it. This lack of understanding can lead to misconceptions, such as assuming that individuals with SCD are “faking” their pain or exaggerating symptoms. The disease’s episodic nature, with pain crises that come and go, can make it harder for others to empathize or understand the severity of the condition.

Confusion with Other Conditions: Sometimes, because SCD is less well-known in certain regions, people might confuse it with other diseases or assume it’s something else entirely. This confusion can lead to incorrect treatment or a lack of appropriate care, adding to the frustration of patients.

2. Stigma Surrounding Pain and Disability:

Invisible Illness: Sickle cell disease often involves chronic pain, fatigue, and other invisible symptoms, meaning that people with the disease may appear healthy to outsiders, despite experiencing severe discomfort. This can lead to the misconception that they are not truly ill, which contributes to a lack of empathy or support.

Frequent Hospitalizations and Absences: Patients with sickle cell disease often have to miss work, school, or social events due to pain crises or hospitalizations. This frequent absence can lead to the perception that the person is lazy, unreliable, or uninterested in their responsibilities, even though their health condition is the underlying cause.

Prejudices about Disability: Some individuals with sickle cell disease may develop long-term complications or disabilities, like joint damage or chronic pain. The perception of these individuals as “disabled” can lead to prejudices about their abilities to participate in regular activities or contribute to society.

3. Cultural and Racial Stigma:

Association with Specific Ethnic Groups: Sickle cell disease predominantly affects people of African, Mediterranean, Middle Eastern, and Indian descent. In regions where these populations are minority groups, SCD can be subject to racial or ethnic stigma. People might unfairly associate the disease with "inferiority" or "genetic weakness" based on cultural stereotypes about the affected communities.

Discrimination in Healthcare: In some cases, the stigma surrounding sickle cell disease can even extend to healthcare settings. Doctors or healthcare workers may display prejudice toward individuals with SCD, either by underestimating the severity of their symptoms or providing suboptimal care because they believe the patient is exaggerating. Racial or ethnic biases in healthcare can further worsen the patient’s experience and health outcomes.

4. Social Isolation and Emotional Toll:

Fear of Social Exclusion: People with sickle cell disease, particularly children, may fear social exclusion or bullying due to their condition. The need to miss school or social events because of pain episodes can lead to feelings of isolation, rejection, or being “different.” They may worry that their friends or classmates won’t understand their condition or that they will be treated differently.

Family and Relationship Strain: The stigma associated with the disease can also affect the patient’s family life. Family members may experience embarrassment, frustration, or social isolation as a result of the patient’s condition. The stigma may prevent families from seeking support or discussing the condition openly, leading to emotional strain and difficulties in coping with the disease.

Mental Health Effects: Chronic stigma and prejudice can contribute to mental health issues, such as depression, anxiety, and low self-esteem. Individuals with SCD may internalize the negative perceptions, leading to a sense of hopelessness or self-doubt. The emotional burden of being misunderstood can also affect their overall well-being and their ability to manage the disease.

5. Impact on Employment and Education:

Workplace Discrimination: People with sickle cell disease may face challenges in the workplace due to their condition. The need for frequent sick leave or hospitalizations can lead to employers viewing them as unreliable or unproductive. This can affect their job security, career advancement, and overall financial stability.

Educational Challenges: Students with sickle cell disease may struggle academically due to frequent absences from school. Teachers and peers may not understand the severity of the illness, leading to frustration and feelings of inadequacy. This can also affect the student's academic performance, relationships with classmates, and their sense of belonging at school.

Difficulty in Pursuing Career Goals: The unpredictability of pain crises and health complications can limit career opportunities for individuals with sickle cell disease. The stigma associated with the disease may also lead to employers being less likely to hire individuals with SCD or offer them promotions, even when they are qualified for the role.

6. Challenges in Relationships and Marriage:

Prejudice in Personal Relationships: People with sickle cell disease may face difficulties in romantic relationships due to the stigma associated with their condition. Partners may fear the future implications of the disease, such as genetic inheritance in children or the stress of managing the disease together.

Genetic Concerns in Marriage: Because sickle cell disease is inherited, people with the disease or sickle cell trait may face challenges in forming relationships, especially in communities where the disease is not well understood. Potential partners may avoid relationships due to the fear of passing on the sickle cell gene, or the stigma of being associated with a chronic illness. In some cases, individuals may also face pressure from their families or communities regarding their choice of partner.

7. Barriers to Accessing Treatment:

Discrimination in Healthcare: As mentioned, the stigma surrounding sickle cell disease can lead to discrimination by healthcare providers. Patients may experience delays in diagnosis, inappropriate treatment, or lack of empathy from healthcare professionals, especially if they are from marginalized racial or ethnic groups. Some healthcare workers may dismiss their pain as "drug-seeking" behavior, leading to inadequate pain management.

Lack of Support Systems: In many regions, especially where sickle cell disease is less common, there may be a lack of social support networks for patients and their families. This lack of support can leave individuals feeling isolated and unsupported, exacerbating the social stigma they already face.

8. Cultural Beliefs and Misconceptions:

In some communities, there may be cultural beliefs or myths about sickle cell disease that contribute to stigma. For example, the disease may be viewed as a punishment for past wrongdoings or as something that only affects "certain kinds of people." These misconceptions can contribute to discrimination, shaming, and rejection of those with the disease.

RESEARCH METHODOLOGY:

The purpose of this research is to provide a comprehensive study of the topic, with the support of international and national literature. Fundamentally, there are two types of research: Qualitative and Quantitative. The present study includes a qualitative research approach. The qualitative research approach is used for the subjective investigation of the research questions by the analysis of non-numeric factors. Analytical research critically evaluates the shred of evidence. The present study is based on secondary data to show the trend and pattern of Sickle Cell Disease (SCD) and the status of the disease across the world. Data has been collected from various published and unpublished records of government, non-government, national, and international organizations.

SIGNIFICANCE OF STUDY:

Research on sickle cell disease is not just a medical or scientific endeavor; it has profound societal significance. By improving early diagnosis, treatment, and prevention, and reducing the social, economic, and healthcare burdens associated with SCD, research can significantly enhance the quality of life for individuals living with the disease. Furthermore, it contributes to the advancement of medical science, promotes social justice, and fosters global collaboration, making it a cornerstone of public health improvement. Research findings can be used to educate the public, reducing misconceptions, stigma, and discrimination associated with the disease. By raising awareness, societies can promote better support for individuals with SCD and their families. Research can bring attention to the disparities in healthcare access, leading to more equitable healthcare policies and initiatives that focus on these vulnerable groups.

OBJECTIVE OF STUDY:

1. To determine the prevalence of SCD and carrier status within the Gond tribe in Chhattisgarh.

2. To increase awareness about SCD among the Gond tribe, focusing on prevention, early diagnosis, and available treatment options.

3. To provide genetic counseling services enabling informed decisions about marriage and childbearing among SCD and carriers.

4. To reduce the social stigma associated with SCD in the Gond tribe by fostering understanding and support within the community.

RESEARCH GAP:

These research gaps highlight the need for a more comprehensive, interdisciplinary approach to studying sickle cell disease, particularly from a sociological standpoint. By addressing these gaps, researchers can contribute to a better understanding of the societal, cultural, and economic factors that impact individuals living with SCD and help guide future interventions, policies, and support systems. There is Limited research on how different cultures, especially indigenous or marginalized communities (e.g., the Gond tribe, African American communities, etc.), perceive sickle cell disease and its impact on family and social life. While physical and medical research on SCD is well-documented, there is insufficient exploration of the psychosocial impact of the stigma that individuals with SCD face, particularly in low-resource settings. Also, there is a lack of in-depth analysis regarding the barriers to healthcare access for individuals with SCD, particularly in rural, underprivileged, or marginalized communities.

RESEARCH QUESTIONS:

1. How does the social stigma associated with SCD impact the mental health and social integration of individuals with the disease?

2. To what extent are members of the Gond tribe aware of sickle cell disease, its genetic transmission, and preventive measures?

3. How do traditional healers and local health practices interact with modern medical knowledge about sickle cell disease in the Gond community?

4. How accessible are healthcare services for individuals with sickle cell disease in the Gond tribe, and what challenges do they face in obtaining treatment?

5. How do geographical and economic factors affect the treatment and management of sickle cell disease in the Gond tribe?

6. How do cultural values influence the decisions regarding marriage and childbearing in families affected by sickle cell disease in the Gond tribe?

7. What coping strategies have individuals and families developed in response to the challenges posed by sickle cell disease within the Gond community?

8. How does the community support families and individuals with sickle cell disease in terms of caregiving, social inclusion, and emotional well-being?

Government Initiatives to Manage Sickle Cell Disease in India:

The Chhattisgarh government is taking a significant step forward by transforming the Sickle Cell Institute, Raipur, into a center of excellence, with an estimated investment of Rs 48.12 crore. This initiative aims to more effectively meet the needs of the population impacted by sickle cell disease (SCD), which affects about 10% of the state's residents. The upgraded facility will not only serve the people of Chhattisgarh but also assist nearby states, particularly Jharkhand. It seeks to promote awareness regarding sickle cell prevention, support early disease detection, and offer essential counseling to those affected to help limit its spread. With 100 beds and various medical amenities, the institute reflects the government's dedication to tackling this significant public health challenge.

Government efforts and the nationwide mission to eradicate sickle cell anemia.:

The Indian government, in partnership with pharmaceutical companies, is exploring the development of a vaccine for sickle cell anemia as part of the National Sickle Cell Anaemia Elimination Mission, launched on July 2023 at Shahdol, Madhya Pradesh. This initiative aims to eliminate the disease by 2047 and includes plans to enhance healthcare facilities, set up blood banks, provide bone marrow transplants, and potentially vaccinate patients. The mission is dedicated to reducing the hardship faced by individuals, especially women and children in tribal areas, where sickle cell disease (SCD) is most common.

It sets a goal to screen over 70 million young people in tribal communities for early detection of the disease and to offer necessary treatments. Moreover, the mission emphasizes awareness-raising and universal screening across 278 districts in 17 states. States like Madhya Pradesh and Chhattisgarh in India have a notably high prevalence of SCD cases.

The Rights of Persons with Disabilities (RPWD) Act of 2016 in India recognizes sickle cell disease as a disability. It is categorized as a "blood disorder" and is included in the list of specified disabilities. This recognition enables individuals with sickle cell disease to benefit from various rights guaranteed by the RPWD Act, including those related to education, employment, accessibility, and social security. Additionally, the Act promotes their integration into society and safeguards them from discrimination. Overall, the RPWD Act represents a significant advancement in enhancing the quality of life for people with disabilities in India, ensuring they have equal opportunities and protection against discrimination.

CONCLUSION:

The widespread occurrence of the sickle cell gene in tribal populations in Chhattisgarh has revealed not only the disease burden and distribution of the sickle gene among the state’s tribal individuals but has also significantly raised the demand of social awareness regarding the condition. Currently, individuals are voluntarily participating in screenings and adopting necessary management and treatment approaches, such as lifestyle changes, counseling before and after marriage, and hydroxyurea therapy. This information can be utilized to connect with their natural history and to devise better strategies for management, control, and ultimately the eradication of the disease. By recognizing the hurdles and stressing the urgency for prompt action, we can address the fact that “sickle cell anemia often goes undetected, particularly in isolated communities, which heightens the risk of transmission and insufficient treatment.” A comprehensive screening effort is essential to assess the extent of the issue, facilitate marriage counseling, and offer tailored support to both patients and carriers. Resource limitations persist, but a coordinated strategy involving patients and the broader community can help maximize the use of existing infrastructure and yield improved outcomes. Advances in research have brought about considerable enhancements in managing sickle cell disease (SCD), such as pain relief, blood transfusions, and innovative therapies like gene therapy and hydroxyurea. Nevertheless, the disease continues to create significant health challenges, and a universal cure has yet to be discovered. Timely diagnosis through newborn screening and access to specialized care are critical for symptom management and complication prevention. Looking ahead, increased awareness, ongoing research, and innovative treatment solutions offer hope for improved outcomes and a possible cure for sickle cell disease. Enhanced healthcare accessibility and patient education are vital for improving the quality of life and longevity of individuals living with this condition.

In India, sickle cell disease primarily impacts tribal communities and underserved areas, making the collaborative initiatives of NGOs and the government essential. By emphasizing awareness, early diagnosis, access to healthcare, genetic counseling, and research, meaningful progress can be achieved in enhancing the lives of individuals affected by sickle cell disease. Collectively, these actions can alleviate the challenges of SCD and enhance health outcomes for upcoming generations.

SUGGESTIONS:

This study is based on completely secondary data due to the unavailability of data. The world-level and National-level data are unavailable in any database. The government institute associated with Sickle cell disease is not willing to provide data in the name of keeping it confidential. Data should be shared by medical institutes so that social scientists and researchers can utilize it for better results, so that it can be used to benefit society. Interdisciplinary research should be promoted to get better outcomes. The Government steps like the ‘National Sickle Cell Anaemia Elimination Mission' Should be executed like the Polio eradication mission, so that the health workers and volunteers can reach door-to-door in difficult-to-reach areas, and raise awareness, provide information about the management and medication of sickle cell disease.

REFERENCES:

1. Adegboyega, L. O. (2021). Psycho-social problems of adolescents with sickle-cell anaemia in Ekiti State, Nigeria. African Health Sciences.

2. April Schueths and Raymona Lawrence 2015. The Sociology of Sickle Cell Disease. Sociology in Focus.

3. Ashley John Duits and hugo Ten Cate. (2024). Sickle Cell Disease; a general overview. The Netherland Journal of Medicine.

4. Bontha v Babu, Parikipandla Sridevi, et. al. (2020). Improving the Capacity of Health Syatem and Community for Sickle Cell Disease Screening and Management Among tribal Population in India: Protocol of an Intervention Study. Current Health Sciences journal, 270-279.

5. Bourke, J. (2023). Sickle Cell Disease: A Cultural History. Gresham College England. London.

6. Camila Freitas de Andrade Rodrigues; Thiago Alves rodrigues; Eduardo Jose Silva Gomes de Oliveria; Jora Batista Santos Gracia and Maria do Socorro de Sousa cartagenes. (2021). Prejudice imparing quality of life in sickle cell disease patients in a developing country: face of suffering. Hematology, Transfusion and Cell Therapy, 1-8.

7. David Reich, Kumarasamy Thangaraj and et. al. (2009). Reconstructing Indian Population History. Nature, 489-495.

8. Deepak Saxena, Sandual Yasobant, et.al. (2017). Situational Analysis of Sickle Cell Disease in Gujrat, India. Indian Journal of Community Medicine.

9. Drue h. Barrett; Ira E. Wisotzek; Gene G. Abel and Joanne l. Rouleau. (1988). Assessment of Psychosocial Functionning of Patients with Sickle Cell Disease. Southern Medical Journal.

10. Gayatri Desai, Ankit Anand, et.al. (2017). Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujrat, India. Journal of Health, Population and Nutrition.

11. H. Mishra and A. Neralwar. (2019). Prevalence of Sickle Cell Disease Among School-age Children in Chhattisgarh, India: Predictions, Implications and Interventions. Journal of Health Management.

12. Ifeyinwa Osunkwo; Biree Andemariam and et. al. (2020). Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle cell World Assessment Survey (SWAY). Ajh wiley.

13. Isabel nascimentodos Santos; Jorginetede jesus Damiao; Maria de Jesus Mendes da fonseca; Claudia da Santos Cople-rodrigues; Odaeia Barbosa de Aguiar. (2019). Food insecurity and social support in families of children with sickle-cell disease. Journal de Pediatria, 306-313.

14. Issac Odame and Dipty Jain. (2020). Sickle cell disease: Progress made and challenges ahead. Indian J Med Res, 505-508.

15. Jain, Dipty., Gupta, Mihir, and et. al. (2024). Sickle Cell disease in India: Current status and progress. Global Haematology, 322-323.

16. Jude U. ohaeri; Wuraola A. Shokunbi; kehinde S. Akinlade and Lola O. Dare. (1995). The Psychosocial Problems of Sickle Cell Disease Sufferers and Their Methods of coping. Pergamon, 955-960.

17. karl Atkin; Shenaz Ahmed; Jenny Hewison and Josephine M. Green. (2008). Decision-Making and Ante-Natal Screening for Sickle Cell and Thalassaemia Disorders. Current Sociology, 77-98.

18. M. kaur; CBS Dangi; et.al. (2013). Burden of Sickle Cell Diseases Among Tribes of India-A Burning Problem. International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS), 60-80.

19. Manase Kilonzi, Dorkasi L. Mwakawanga, et. al. (2022). The Effects of Sickle Cell Disease on the Quality of Life: A Focus on the Untold Experience of Parents in tanzania. International Journal of Environmental research and Public health.

20. Marilyn D. Farber; Mabel Koshy; Thomas R. Kinney. (1985). Cooperative Study of Sickle Cell Disease: Demographic and Socioeconomic Characteristics of Patients and families with Sickle Cell Disease. Pergamon, 495-505.

21. Mihir Rupani, Bipin Chandulai, et.al. (2012). Reaching Community Through School going Children for Sickle Cell Disease in Zankhvav Village of Surat District, Western India. Online Journal of Health and Allied Sciences.

22. P. K. Patra; P.K Khodiar; I. R. Hambleton and G. R. Serjeant. (2015). The Chhattisgarh state screening programme for the sickle cell gene: a cost-effective approach to a public health problem. Journal of Community Genetics.

23. Patricia Stebbins; Cory Saucier, et.al. (2022). Impact of Sickle Cell Disease on work, school, relationshis, and Social Life: Results from in-depth Interview with Patients. European Hematology Association.

24. Pradeep K. Patra; Virander S. Chauhan; Prafull K. Khodiar; Abdul R. Dalla and Graham R. Serjeant. (2011). Screening for the Sickle Cell gene in Chhattisgarh State, India: an approach to a major public health problem. Journal of Community Genetics.

25. Prithu Sundd and Enrico M Novelli. (2019). Pathophysiology of Sickle Cell Disease. Annual Review of Pathology Mechanisms of Disease.

26. Putul, A. (2017). Sickle cell: A silent killer in Chhattisgarh State. Aljazeera.

27. R. Kishor; Mihir Gupta; Kalpna Gupta. (2023). A new era dawns on sickle cell disease in India. Indian Journal of Medical Research, 1-8.

28. R. Kumar; B. Sahu; R. Yadav; R. Shanmugam. (2022). Geographical And Ethnic Distribution of Sickle Cell Disease in Madhya Pradesh and Chhattisgarh State of India. HemaSphere.

29. Ravi K. Konuri and Swapan K Kolay. (2017). Prevalence of Sickle Cell Anemia: A Study on Bastar Region. Indian Journal of Research In Anthropology.

30. Ravindra kumar; Rajasubramaniam Shanmugam and Aparup Das. (2022). Sickle cell disease in India: Prevention-driven social and public health implications. Clinical Epidemiology and Global Health.

31. Roshan B. Colah, Malay b. Mukherjee, et. al. (2015). Sickle cell disease in tribal populations in India. Indian j Med Res, 509-515.

32. Salih, K. M. (2019). The Impact of Sickle cell anemia on the quality of life of sicklers at school age. Journal of Family Medicine and Primary care.

33. Sandeep S. Gunjal, Humne Arun, et. al. (2012). Prevalence of Sickle cell disorder and anaemia in Tribal School Students from Central India. International Journal of Collaborative research on Internal medicine and Public Health.

34. Sumanta Panigrahi; P. K. Patra and P. K. Khodiar. (2015). The Screening and Morbidity Pattern of Sickle Cell Anemia in Chhattisgarh. Indian Journal of Hematology and Blood Transfusion.

35. Sunil, P. (2023). Chhattisgarh's Sickle Cell Disease Problem. Health On AIR.

36. Thomas n. Williams and Swee Lay Thein. (2018). Sickle Cell Anemia and Its Phenotypes. Annual Review of Genomics and Human genetics, 113-47.

37. Vijay Bhagat, Shubhangi Baviskar, et. al. (2014). Poor Health Related Quality of Life Among Patients of Sickle Cell Disease. Indian Journal of Palliative Care.

38. Vineet Raman; Tanya Seshadri; Sangeeta V Joice and Prashanth N Srinivas. (2021). Sickle cell disease in India: a scoping review from a heath systems perspective to identify an agenda for research and action. BMJ Glob Health.

39. Zaman, M. (2010). Marriage of Cousins: Congenital disease and People's Perceptions in Pakistan, a Public health Challenge. Journal of Public Health Policy, 381-383.

Received on 08.10.2025 Revised on 22.10.2025

Accepted on 05.11.2025 Published on 14.11.2025

Available online from November 25, 2025

Int. J. of Reviews and Res. in Social Sci. 2025; 13(4):191-202.

DOI: 10.52711/2454-2687.2025.00028

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.